Eating Disorders as Mental Disorders: Diagnostic Criteria, Neurobiology, Risk Factors, and Evidence-Based Treatment

Eating disorders are psychiatric conditions characterized by persistent disturbances in eating behavior and related thoughts and emotions, with significant impairment in health and functioning. Clinically, they are classified as mental disorders because their core features involve maladaptive cognitive-emotional processes, including distorted body image, intense fear of weight gain, rigid dietary or compensatory behaviors, and reinforcement of illness-related beliefs. The DSM-5-TR framework groups eating disorders such as anorexia nervosa, bulimia nervosa, and binge-eating disorder under mental health diagnoses, reflecting their psychological drivers and shared neurobiological mechanisms.

Anorexia nervosa involves restriction of energy intake leading to significantly low body weight, alongside cognitive psychopathology: overvaluation of weight/shape, persistent behaviors interfering with weight gain, and denial of seriousness of low weight. Bulimia nervosa is defined by recurrent binge eating paired with recurrent compensatory behaviors (e.g., vomiting, misuse of laxatives, excessive exercise) and inappropriate influence of body shape/weight on self-evaluation. Binge-eating disorder includes recurrent binge episodes without regular compensatory behaviors and is associated with distress, shame, and heightened risk for comorbid depression and anxiety.

A key concept is that eating disorders are not merely “habits” or lifestyle choices; they represent an interaction between vulnerability and triggers. Vulnerability can be genetic, developmental, and neurobiological. Heritability estimates are substantial across eating disorder subtypes, and twin and family studies support inherited risk. Environmental and cultural factors also matter, including exposure to weight stigma, dieting culture, traumatic experiences, and stress. Importantly, these influences do not act in isolation: they shape learning and reinforcement of maladaptive coping strategies, such that food restriction, binge eating, or purging may temporarily reduce anxiety or provide a sense of control, thereby strengthening the cycle.

Neurobiologically, eating disorders involve altered signaling in reward, stress, and appetite regulation pathways. Dysregulation of serotonergic and dopaminergic systems has been implicated in mood, impulse control, and reward processing. The hypothalamic-pituitary axis and cortisol responses may be abnormal, contributing to heightened stress sensitivity. Additionally, changes in metabolic and endocrine status can perpetuate psychopathology. For example, starvation can affect neurotransmission and cognitive flexibility, reinforcing rigidity and increasing irritability. Purging behaviors can lead to electrolyte disturbances that worsen mood, cognition, and physical stability.

Cognitive-emotional mechanisms are central. Individuals often exhibit attentional bias toward body-related cues, cognitive distortions about shape and weight, and perfectionism or harm-avoidant traits. In bulimia nervosa and binge-eating disorder, binge episodes are frequently linked to affect regulation difficulties: intense negative affect can trigger binge behavior, followed by guilt or attempts to counteract intake. Emotion dysregulation, impulsivity, and comorbid disorders (major depressive disorder, anxiety disorders, obsessive-compulsive disorder) are common and influence prognosis.

Medical consequences are severe and underscore the need for integrated care. Malnutrition in anorexia nervosa can cause bradycardia, hypotension, hypothermia, osteoporosis, amenorrhea, lanugo, and hematologic abnormalities. In bulimia nervosa and binge-eating disorder, complications include gastrointestinal injury, dental enamel erosion, and acute electrolyte imbalances from purging, such as hypokalemia leading to arrhythmias. Therefore, while eating disorders are mental disorders, they are simultaneously disorders of health requiring medical monitoring, including cardiac evaluation, laboratory testing, and nutritional assessment.

Assessment typically involves a comprehensive psychiatric evaluation, measurement of severity (e.g., BMI and weight trajectory in anorexia nervosa; frequency of binge and compensatory behaviors in bulimia nervosa and binge-eating disorder), and screening for medical risk. Clinicians also evaluate comorbidities, history of trauma, and current safety concerns. Treatment is evidence-based and should be tailored to subtype and severity.

Psychological therapies are foundational. Cognitive-behavioral therapy is well-supported for bulimia nervosa and binge-eating disorder, targeting maladaptive beliefs, interruption of binge-purge cycles, and development of coping skills. For anorexia nervosa, family-based therapy is a standard approach for adolescents and can be adapted for adult contexts emphasizing supportive behavioral change. Dialectical behavior therapy may help with emotion regulation and impulse control, particularly when self-harm or severe affect dysregulation is present.

Pharmacotherapy can be adjunctive. Antidepressants, particularly selective serotonin reuptake inhibitors, are commonly used for bulimia nervosa and binge-eating disorder, especially when comorbid depression or persistent binge episodes are present. Medication does not replace nutrition rehabilitation or psychotherapy; rather, it supports symptom reduction and relapse prevention.

Recovery is possible, but outcomes vary. Early intervention improves prognosis, while chronicity increases medical risk and entrenches illness behaviors. Interdisciplinary care—psychiatry, primary care or pediatrics, nutrition therapy, and when needed cardiology—is the safest approach. A mental disorder framework guides clinicians toward effective psychiatric treatments, while medical management addresses systemic complications, affirming that eating disorders are psychiatric illnesses with profound bodily impacts. Source: [viomatomat]